Emulate
Developer of microfluidic Organ-on-a-Chip microphysiological systems and an integrated emulation platform for human-relevant preclinical research. Supplies lab-ready consumables, automated culture instrumentation, isogenic and patient-derived co-culture models, and analysis workflows to support prediction of human safety, efficacy, ADME, and mechanism-of-action while engaging regulatory qualification pathways and enabling scalable workflows.
Industries
Nr. of Employees
medium (51-250)
Emulate
Boston, Massachusetts, United States
Patents
Controller and flexible coils for administering therapy, such as for cancer therapy
US-11103721-B2
View DetailsController and flexible coils for administering therapy, such as for cancer therapy
US-10046172-B2
View DetailsSystem and method for collecting, storing, processing, transmitting and presenting very low amplitude signals
US-9417257-B2
View DetailsMagnetic particles having one or more fluorescence detectable moieties positioned asymmetrically with respect to the magnetic pole regions of the particle for using in detecting and characterizing an analyte; magnetic relaxation immunoassay; ligand-receptor binding determination
US-7575934-B2
View Details
Controller and flexible coils for administering therapy, such as for cancer therapy
US-11103721-B2
View DetailsController and flexible coils for administering therapy, such as for cancer therapy
US-10046172-B2
View DetailsSystem and method for collecting, storing, processing, transmitting and presenting very low amplitude signals
US-9417257-B2
View DetailsMagnetic particles having one or more fluorescence detectable moieties positioned asymmetrically with respect to the magnetic pole regions of the particle for using in detecting and characterizing an analyte; magnetic relaxation immunoassay; ligand-receptor binding determination
US-7575934-B2
View DetailsProducts
Liver Organ-Chip BioKit (quad-culture)
BioKit for perfused culture of primary human hepatocytes with non-parenchymal liver cells to assess metabolism and hepatotoxicity under continuous flow.
Stretchable Organ-Chip consumable for biomechanical models
Stretchable microfluidic consumable enabling application of cyclic mechanical strain for models that require biomechanical stimulation (e.g., lung, heart, vasculature).
Rigid low-adsorption Organ-Chip consumable
Rigid thermoplastic consumable validated to reduce small lipophilic drug adsorption for more reproducible metabolism and toxicology assays.
Open-chamber Organ-Chip consumable for 3D patterning
Consumable with accessible chamber architecture for 3D tissue patterning and hydrogel applications used in engineered tissue constructs and spatially patterned models.
Automated culture module for perfused Organ-Chip maintenance
Automated culture module that maintains Organ-Chip perfusion and environmental conditions as part of an integrated emulation system for long-term experiments.
Integrated Organ-Chip emulation platform
Combined platform of Organ-Chips, culture instrumentation, and software applications intended to recreate human tissue microphysiology for research, ADME, toxicology, and translational studies.
Liver Organ-Chip BioKit (quad-culture)
BioKit for perfused culture of primary human hepatocytes with non-parenchymal liver cells to assess metabolism and hepatotoxicity under continuous flow.
Stretchable Organ-Chip consumable for biomechanical models
Stretchable microfluidic consumable enabling application of cyclic mechanical strain for models that require biomechanical stimulation (e.g., lung, heart, vasculature).
Rigid low-adsorption Organ-Chip consumable
Rigid thermoplastic consumable validated to reduce small lipophilic drug adsorption for more reproducible metabolism and toxicology assays.
Open-chamber Organ-Chip consumable for 3D patterning
Consumable with accessible chamber architecture for 3D tissue patterning and hydrogel applications used in engineered tissue constructs and spatially patterned models.
Automated culture module for perfused Organ-Chip maintenance
Automated culture module that maintains Organ-Chip perfusion and environmental conditions as part of an integrated emulation system for long-term experiments.
Integrated Organ-Chip emulation platform
Combined platform of Organ-Chips, culture instrumentation, and software applications intended to recreate human tissue microphysiology for research, ADME, toxicology, and translational studies.
Services
Joint research programs and embedded scientist support to integrate Organ-Chip capabilities within partner laboratories for co-development and application studies.
Project-based collaborations to generate Organ-Chip data, participate in regulatory pilots, and support contexts of use for regulatory submissions and qualification activities.
Design and implementation of Organ-Chip studies for preclinical assessment (safety, ADME, transport, mechanism) including kit-based delivery, study protocols, and scalability support.
Joint research programs and embedded scientist support to integrate Organ-Chip capabilities within partner laboratories for co-development and application studies.
Project-based collaborations to generate Organ-Chip data, participate in regulatory pilots, and support contexts of use for regulatory submissions and qualification activities.
Design and implementation of Organ-Chip studies for preclinical assessment (safety, ADME, transport, mechanism) including kit-based delivery, study protocols, and scalability support.
Expertise Areas
- Organ-on-a-Chip microphysiological systems
- Preclinical safety and toxicology assessment
- ADME and PBPK translation using in vitro data
- iPSC-derived isogenic multi-lineage modeling
Key Technologies
- Microfluidic organ-on-chip devices
- Continuous perfusion culture
- Cyclic biomechanical (stretch) stimulation
- iPSC-derived multi-lineage co-culture
News & Updates
Launch of an isogenic neurovascular Organ-Chip model for blood–brain barrier transport and neuroinflammation studies (press announcement).
Agency-wide CRADA to deploy Organ-Chips across FDA laboratories for studies including vaccine safety, Alzheimer’s, microbiome, and individualized liver toxicity research (announcement).
Study demonstrating establishment of Duodenum Intestine-Chip from individual donors using biopsy-derived organoids, enabling personalized preclinical testing and clinical pharmacology studies including inter-individual ADME differences and PBPK integration.
Description of a collaboration using bone marrow Organ-Chips derived from astronaut donors to study spaceflight effects on human tissues.
Acceptance of a Liver Organ-Chip into an FDA pilot program evaluating its use in drug-induced liver injury contexts.
Completed a $36 million Series C financing round to expand product suite and commercialization of the emulation platform.
Launch of an isogenic neurovascular Organ-Chip model for blood–brain barrier transport and neuroinflammation studies (press announcement).
Agency-wide CRADA to deploy Organ-Chips across FDA laboratories for studies including vaccine safety, Alzheimer’s, microbiome, and individualized liver toxicity research (announcement).
Study demonstrating establishment of Duodenum Intestine-Chip from individual donors using biopsy-derived organoids, enabling personalized preclinical testing and clinical pharmacology studies including inter-individual ADME differences and PBPK integration.
Description of a collaboration using bone marrow Organ-Chips derived from astronaut donors to study spaceflight effects on human tissues.
Acceptance of a Liver Organ-Chip into an FDA pilot program evaluating its use in drug-induced liver injury contexts.
Completed a $36 million Series C financing round to expand product suite and commercialization of the emulation platform.